• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部晚期胃癌的综合生存列线图:一项基于大人群的真实世界研究。

Comprehensive survival nomograms for locally advanced gastric cancer: a large population-based real-world study.

作者信息

Maimaiti Aizezi, Zhou Yuan, Wang Dan, Zhou Zhongyi, Pei Haiping, Li Yuqiang

机构信息

Department of General Surgery, Xiangya Hospital, Central South University, Changsha, China.

The National Clinical Research Center for Geriatric Disorders (Xiangya Hospital), Central South University, Changsha, China.

出版信息

Transl Cancer Res. 2023 Nov 30;12(11):2989-3006. doi: 10.21037/tcr-22-1255. Epub 2023 Nov 24.

DOI:10.21037/tcr-22-1255
PMID:38130296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10731340/
Abstract

BACKGROUND

This study aimed to construct and verify nomograms predicting overall survival (OS) and cancer-specific survival (CSS) for locally advanced gastric cancer (LAGC) based on a therapeutic selection, demographic factors, and pathological features.

METHODS

The data used for the analysis were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Nomograms were constructed based on the Cox regression model.

RESULTS

The entire cohort comprised 21,757 patients with histologically confirmed LAGC, and was randomly distributed into training and verification groups at a ratio of 2:1 for building the prognostic predictive model. According to the multivariate analysis, 13 variables [i.e., age, marital status, race, tumor location, pathological grade, histological type, T and N stage, surgery, radiotherapy, chemotherapy, tumor size, and regional nodes examined (RNE)] were confirmed as independent predictors for both OS and CSS. All of the significant variables were used to create the nomograms for OS and CSS. Time-dependent receiver operating characteristic (ROC) curves, a decision curve analysis (DCA), the C-index, and calibration curves were applied to identify the discriminating superiority of the nomograms.

CONCLUSIONS

The nomograms for OS and CSS in LAGC were built and validated based on the therapeutic selection and pathological and demographic variables using a national database. This study aims at helping clinicians make better clinical decisions and encouraging patients receive treatment actively.

摘要

背景

本研究旨在基于治疗选择、人口统计学因素和病理特征构建并验证预测局部晚期胃癌(LAGC)总生存期(OS)和癌症特异性生存期(CSS)的列线图。

方法

用于分析的数据取自监测、流行病学和最终结果(SEER)数据库。基于Cox回归模型构建列线图。

结果

整个队列包括21757例经组织学确诊的LAGC患者,并以2:1的比例随机分为训练组和验证组以构建预后预测模型。根据多变量分析,13个变量[即年龄、婚姻状况、种族、肿瘤位置、病理分级、组织学类型、T和N分期、手术、放疗、化疗、肿瘤大小和检查的区域淋巴结(RNE)]被确认为OS和CSS的独立预测因素。所有显著变量均用于创建OS和CSS的列线图。应用时间依赖性受试者工作特征(ROC)曲线、决策曲线分析(DCA)、C指数和校准曲线来确定列线图的鉴别优势。

结论

利用国家数据库,基于治疗选择以及病理和人口统计学变量构建并验证了LAGC的OS和CSS列线图。本研究旨在帮助临床医生做出更好的临床决策,并鼓励患者积极接受治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c0/10731340/945bdb08c543/tcr-12-11-2989-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c0/10731340/677c40d0f76d/tcr-12-11-2989-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c0/10731340/556a2c4bccfe/tcr-12-11-2989-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c0/10731340/36a936317d34/tcr-12-11-2989-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c0/10731340/6a97677debdd/tcr-12-11-2989-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c0/10731340/4f20bd6534d2/tcr-12-11-2989-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c0/10731340/bd6a64fb425c/tcr-12-11-2989-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c0/10731340/945bdb08c543/tcr-12-11-2989-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c0/10731340/677c40d0f76d/tcr-12-11-2989-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c0/10731340/556a2c4bccfe/tcr-12-11-2989-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c0/10731340/36a936317d34/tcr-12-11-2989-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c0/10731340/6a97677debdd/tcr-12-11-2989-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c0/10731340/4f20bd6534d2/tcr-12-11-2989-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c0/10731340/bd6a64fb425c/tcr-12-11-2989-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14c0/10731340/945bdb08c543/tcr-12-11-2989-f7.jpg

相似文献

1
Comprehensive survival nomograms for locally advanced gastric cancer: a large population-based real-world study.局部晚期胃癌的综合生存列线图:一项基于大人群的真实世界研究。
Transl Cancer Res. 2023 Nov 30;12(11):2989-3006. doi: 10.21037/tcr-22-1255. Epub 2023 Nov 24.
2
Developing and validating nomograms for predicting the survival in patients with clinical local-advanced gastric cancer.开发和验证用于预测临床局部晚期胃癌患者生存率的列线图。
Front Oncol. 2022 Oct 26;12:1039498. doi: 10.3389/fonc.2022.1039498. eCollection 2022.
3
Specific survival nomograms based on SEER database for small intestine adenocarcinoma.基于 SEER 数据库的小肠腺癌特定生存诺模图。
Ann Palliat Med. 2021 Jul;10(7):7440-7457. doi: 10.21037/apm-21-600. Epub 2021 Jul 14.
4
Accurate nomograms with excellent clinical value for locally advanced rectal cancer.对于局部晚期直肠癌具有出色临床价值的精确列线图。
Ann Transl Med. 2021 Feb;9(4):296. doi: 10.21037/atm-20-4144.
5
Development and validation of nomograms for predicting overall survival and cancer-specific survival in elderly patients with locally advanced gastric cancer: a population-based study.基于人群的研究:开发和验证用于预测局部晚期老年胃癌患者总生存和癌症特异性生存的列线图。
BMC Gastroenterol. 2023 Apr 11;23(1):117. doi: 10.1186/s12876-023-02749-9.
6
Development and validation of nomograms for predicting overall survival and cancer specific survival in locally advanced breast cancer patients: A SEER population-based study.基于 SEER 人群的研究:预测局部晚期乳腺癌患者总生存和癌症特异性生存的列线图的建立和验证。
Front Public Health. 2022 Sep 20;10:969030. doi: 10.3389/fpubh.2022.969030. eCollection 2022.
7
Establishment and validation of systematic prognostic nomograms in patients over 60 years of age with osteosarcoma: A multicenter external verification study.60 岁以上骨肉瘤患者的系统预后列线图的建立和验证:一项多中心外部验证研究。
Cancer Med. 2023 Apr;12(8):9589-9603. doi: 10.1002/cam4.5736. Epub 2023 Mar 29.
8
Development and validation of prognostic nomograms for early-onset colon cancer in different tumor locations: a population-based study.不同肿瘤部位早发性结肠癌预后列线图的建立与验证:基于人群的研究。
BMC Gastroenterol. 2023 Oct 21;23(1):362. doi: 10.1186/s12876-023-02991-1.
9
Development of nomograms for predicting the survival of intestinal-type gastric adenocarcinoma patients after surgery.建立预测肠型胃腺癌患者手术后生存的列线图。
Sci Rep. 2023 Oct 13;13(1):17430. doi: 10.1038/s41598-023-44671-w.
10
Nomograms predicting Overall Survival and Cancer-specific Survival for Synchronous Colorectal Liver-limited Metastasis.预测同时性结直肠癌肝局限性转移患者总生存期和癌症特异性生存期的列线图。
J Cancer. 2020 Aug 27;11(21):6213-6225. doi: 10.7150/jca.46155. eCollection 2020.

引用本文的文献

1
Perform tumor-specific survival analysis for Merkel cell carcinoma patients undergoing surgical resection based on the SEER database by constructing a nomogram chart.基于监测、流行病学和最终结果(SEER)数据库,通过构建列线图对接受手术切除的默克尔细胞癌患者进行肿瘤特异性生存分析。
Open Med (Wars). 2025 Mar 21;20(1):20241103. doi: 10.1515/med-2024-1103. eCollection 2025.
2
Application and progress of nomograms in gastric cancer.列线图在胃癌中的应用与进展
Front Med (Lausanne). 2025 Jan 29;12:1510742. doi: 10.3389/fmed.2025.1510742. eCollection 2025.

本文引用的文献

1
Lymphopaenia and accidental splenic doses: Do they have any prognostic value for locally advanced gastric cancer patients treated with radiochemotherapy?淋巴细胞减少症与脾脏意外受量:对于接受放化疗的局部晚期胃癌患者,它们有任何预后价值吗?
Contemp Oncol (Pozn). 2019;23(4):226-233. doi: 10.5114/wo.2019.91524. Epub 2019 Dec 30.
2
Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy.预测接受手术和化疗的胃腺癌患者生存情况的列线图。
BMC Cancer. 2020 Jan 6;20(1):10. doi: 10.1186/s12885-019-6495-2.
3
Predicting pathological complete response by comparing MRI-based radiomics pre- and postneoadjuvant radiotherapy for locally advanced rectal cancer.
基于 MRI 的放射组学比较新辅助放疗前后预测局部晚期直肠癌的病理完全缓解。
Cancer Med. 2019 Dec;8(17):7244-7252. doi: 10.1002/cam4.2636. Epub 2019 Oct 22.
4
Radiomic analysis for pretreatment prediction of response to neoadjuvant chemotherapy in locally advanced cervical cancer: A multicentre study.基于影像组学的局部晚期宫颈癌新辅助化疗疗效预测的多中心研究
EBioMedicine. 2019 Aug;46:160-169. doi: 10.1016/j.ebiom.2019.07.049. Epub 2019 Aug 6.
5
The main contributor to the upswing of survival in locally advanced colorectal cancer: an analysis of the SEER database.局部晚期结直肠癌生存率上升的主要因素:基于监测、流行病学和最终结果(SEER)数据库的分析
Therap Adv Gastroenterol. 2019 Jul 18;12:1756284819862154. doi: 10.1177/1756284819862154. eCollection 2019.
6
The Relationship between Primary Gross Tumor Volume and Tumor Response of Locally Advanced Rectal Cancer: pGTV as a More Accurate Tumor Size Indicator.局部进展期直肠癌原发大体肿瘤体积与肿瘤反应的关系:pGTV作为更准确的肿瘤大小指标
J Invest Surg. 2021 Feb;34(2):181-190. doi: 10.1080/08941939.2019.1615153. Epub 2019 May 22.
7
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
8
Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.多参数 MRI 的放射组学分析预测局部晚期直肠癌新辅助放化疗的病理完全缓解。
Eur Radiol. 2019 Mar;29(3):1211-1220. doi: 10.1007/s00330-018-5683-9. Epub 2018 Aug 20.
9
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.全球癌症生存趋势监测 2000-14 年(CONCORD-3):对来自 71 个国家 322 个基于人群的登记处的 37513025 名诊断患有 18 种癌症之一的患者的个体记录进行分析。
Lancet. 2018 Mar 17;391(10125):1023-1075. doi: 10.1016/S0140-6736(17)33326-3. Epub 2018 Jan 31.
10
Development and Validation of a Nomogram to Predict the Benefit of Adjuvant Radiotherapy for Patients with Resected Gastric Cancer.预测胃癌切除患者辅助放疗获益的列线图的开发与验证
J Cancer. 2017 Sep 29;8(17):3498-3505. doi: 10.7150/jca.19879. eCollection 2017.